Report License
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Order Review
Recombinant Protein Therapeutics CDMO Market – Type (Oncology Agents, Insulin, Interferon, Vaccine), Source (Mammalian, E. coli), Therapeutic Area (Oncology, Immunological, Metabolic Disorders), Service Type, End-user, Global Forecast (2024 – 2032)
Report ID: GMI8819
Selected License: $4,850
Discount: $727
Order Total: $4,123
Need assistance?
Call us or write to us:
Phone : +1-302-846-7766
Toll-Free : +1-888-689-0688
Email: sales@gminsights.com
What You Get?
- Report accessible by one user only
- 24 hours of customization free with purchase
- Delivery in 24 to 72 hours
- Up to 3 months post-purchase service
- PDF report
